Brain cancer breakthrough
We are delighted to announce the publication of an exciting breakthrough in the lab at the University of Sussex. The team has made important progress in developing the first ever blood test to diagnose an aggressive form of brain cancer called Glioblastoma.
This test could mean a quicker diagnosis, which is invaluable for patients with such a tumour that severely cuts life expectancy. At present, life expectancy is only 15 months after diagnosis of this type of brain cancer. In addition, the test could be used to check how effectively treatments are working for patients and to monitor for any relapses.
Action Against Cancer is delighted to support this pioneering research.
The breakthrough has been widely reported in the scientific press, with a few examples listed here: